INTRODUCTION
Peripheral arterial disease (PAD) predominantly affects the elderly and prevalence increases with age in both genders. 1, 2 Its prevalence in the general population varies from 4 to 10% and can exceed 20% in patients over the age of 70. 3 Despite this, there is a low prevalence of symptomatic patients with intermittent claudication. 1, 2 Few epidemiologic studies of PAD have been conducted in Brazil. One multicenter study 4 described a PAD prevalence of 10.5% in the general population and found that only 9% of patients reported claudication.
There is a strong association between PAD and Diabetes Mellitus (DM), 5, 6 but PAD prevalence rates have not been determined in diabetes patients with the same degree of precision as in the general population. Peripheral arterial disease is a major risk factor for lower-extremity amputation 7-10 and patients with PAD and diabetes are at greater risk of amputations than PAD patients free from diabetes. 11 Patients with DM have a high risk of developing PAD, and early identification of this disease is potentially a clinical strategy for reducing morbidity and mortality in this population. 6, 11 Impacts on quality of life (QoL) have been described in both diseases, diabetes and PAD. [12] [13] [14] [15] In PAD, symptom severity is associated with worse quality of life indices. 12 Furthermore, PAD progression may correlate with reduced physical function.
In view of the fact that there is a paucity of epidemiological data on the prevalence of PAD in the Brazilian population, particularly among patients with diabetes, and also that the impact PAD has on quality of life and physical activity in patients with diabetes without prior diagnosis of PAD is not yet well established, we conducted a study with the objective of determining the prevalence of PAD and assessing its impact on quality of life, physical activity levels and body composition in a sample of diabetic patients treated by the public health system at a University Hospital in Brazil.
METHODS

Subjects
The study enrolled volunteers with diagnoses of type 2 diabetes mellitus (T2DM) who were being monitored and given treatment for DM at the Endocrinology outpatients clinic at Onofre Lopes University Hospital (HUOL-UFRN) in Natal, Brazil. All patients were treated by the Brazilian public health system (SUS -Sistema Único de Saúde).
Sample size was calculated using methodology described by Lwanga and Lemeshow, 16 based on data that estimated PAD prevalence in DM patients at 20% to 29% (identified using the same method employed in the present study, i.e., ABI), 10 for an absolute precision of 10 and a significance level of 5%, resulting in a sample size of 72 subjects.
For inclusion in the study, subjects had to have been diagnosed with T2DM and have no prior diagnoses of: PAD, advanced heart disease such as chronic heart failure, diabetic neuropathy, neuromuscular disease or rheumatic or metabolic diseases (except DM), which could influence the exercise capacity assessments administered during clinical assessment. Patients with previous amputations or who had received revascularization of coronary or peripheral arterial beds were excluded from the study.
Patients were invited to participate on days on which they were attending the outpatients clinic. After a brief interview and review of clinical records, volunteers were enrolled on the study if they met the inclusion criteria and gave their written consent as required by the Research Ethics Committee at the HUOL-UFRN (approval number 421/10) and in accordance with Brazilian legislation (res. 196/96) and the Helsinki Declaration.
Anthropometric measurements
Body weight and height were measured using a mechanical scale with a stadiometer attached (Welmy, Brazil). Body mass index (BMI) was classified according to World Health Organization 17 recommendations. Waist and hip circumference and the waist-to-hip ratio (WHR) were measured using methodology that had been described elsewhere. 18
Body composition
Body composition was assessed using the Direct Segmental Multi-frequency Bioelectrical Impedance method, as described elsewhere. 19, 20 An Inbody R20 portable body composition analyzer (Biospace, South Korea) with eight electrodes, two for each foot and two for each hand, was used to determine segmental electrical impedance using a 250 µA current at frequencies of 20 kHz and 100 kHz. Total body water (TBW) was calculated using five segmental impedance measurements. Muscle mass was estimated from TBW assuming a hydration of fat-free mass (FFM) rate of 73.2%. Fat mass (FM) was calculated by subtracting FFM from body weight. Body fat mass was also expressed as body fat percentage (BFP). Basal metabolic rate (BMR) was calculated using a regression equation based on FFM. Body Fat Mass Index (BFMI) was calculated as the ratio of body FM (Kg) by Height (m) squared (Kg/m 2 ).
Ankle-brachial index (ABI)
The ankle-brachial index (ABI) was measured by a single trained examiner using a sphygmomanometer (Durashock DS44, WelchAllyn/Tycos  ) with cuffs suitable for the circumferences of the patients' limbs and a 10MHz portable Doppler machine (DV-10, Microem).
Ankle-brachial index was determined for each leg by taking the ratio between the highest systolic blood pressure measured at the ankle (posterior tibial and dorsalis pedis arteries) and the highest systolic blood pressure measured in the arms (brachial artery). 3, 21 The test methodology and ABI classification were based on American College of Cardiology/American Heart Association (ACC/AHA) recommendations. 21, 22 Ankle-brachial index values from 0.91 to 1.39 were considered normal. Values equal to or less than 0.90 were considered compatible with PAD and values equal to or greater than 1.40 were considered abnormal but inconclusive for PAD, designating non-compressible arteries that require additional assessments by other techniques for identification or exclusion of PAD. 3, 21 Peripheral arterial disease was classified as mild to moderate where ABI values fell between 0.41 and 0.9 and severe for values lower than 0.4. 21, 22 
Quality of life
Quality of life was assessed using the SF-36 health-related quality of life questionnaire (Medical Outcomes Short Form 36), as translated into Portuguese and adapted for the Brazilian population. 23 Although the questionnaire is self-administrable, it was administered during interviews.
To aid with analysis and interpretation, scores were also standardized using standard deviations from the general population (Z-scores, mean of 50 and standard deviation of 10). Standardized values were calculated using data from a 1998 national survey of the US population (SF-36v2™ Health Survey 1998 U.S. general population norms) and from algorithms based on scoring standardized to eight domains of the questionnaire, available at www. sf-36.org (Norm base score calculator, accessed on January, 2012). The results are shown in the form of two summaries, the Physical Component Summary (PCS) and Mental Component Summary (MCS).
Physical activity levels
Physical activity levels were assessed using the Modified Baecke Questionnaire, as translated into Portuguese and validated. 24 This consists of a recall of energy expenditure in the last twelve months. Although this questionnaire is also selfadministrable, it too was administered during interviews. For the Baecke questionnaire, total scores (TS) were used for statistical analysis.
Statistical analysis
Results are expressed as means and standard deviations. Patients were divided into two groups on the basis of ABI results: a normal ABI group, for those with normal ABI values and a PAD ABI group, for patients with ABI results ≤ 0.90. Volunteers whose ABI was > 1.40 were excluded from the groups used to compare variables and from the correlation coefficient calculations, because these ABI values are inconclusive for PAD diagnosis. 3, 21 Therefore, as described in greater detail in the results section, 66 patients from the total of 73 assessed were classed as having normal ABI (n=56) or PAD ABI (n=10), for the purposes of comparing variables.
Normality of data was verified using the Kolmogorov-Smirnov test. The Mann-Whitney test was used to compare variables between groups. Correlations were identified by calculating Spearman correlation coefficients (ρ). Where correlation tests involved ABI results, the lowest numerical ABI value for each patient was used. The Chi-Square test was used to test associations between frequencies of smoking, high blood pressure and insulin use and membership of each of the two groups of volunteers. Values of P<0.05 were adopted as the criterion for statistical significance. The software packages used for statistical calculations were Graphpad Prism 4.0 for Windows and the Statistical Package for the Social Sciences-SPSS 17.0.
RESULTS
A total of 73 patients, 51 women (69.8%) and 22 men (30.2%), met all inclusion criteria and were therefore included in the study. Data describing the general characteristics of the population and the groups of patients with normal ABI and PAD ABI are shown in Table 1 . No statistical differences were detected when the variables were compared between groups, with the exception of a trend to exhibit higher systolic blood pressure in the PAD ABI group (P=0.0502).
The results showed that 23.2% (17/73) of the patients had abnormal ABI values and that the prevalence of patients with ABI compatible with a diagnosis of PAD was 13.7% (10/73). Seven patients had ABI values > 1.40 (9.6%). Therefore, from a total of 73 patients assessed, 66 were classified as having normal ABI (n=56) or PAD ABI (n=10) for the purposes of comparing variables.
The means and standard deviations for ABI values of the normal ABI group and the PAD ABI group were 1.10±0.08 and 0.93±0.17 for the right side and 1.08±0.08 and 0.83±0.13 for the left side respectively. The mean and standard deviation for the lowest ABI value of individuals with PAD were 0.83±0.12.
The means and standard deviations for the quality of life questionnaire physical health summary (PCS) and mental health summary(MCS) and for the modified Baecke questionnaire total scores (TS) are shown in Table 2 . There were no statistical differences between groups when these variables were compared. However, the population of patients with both diabetes and PAD had physical health summary scores (PCS=38.1±11.1) one standard deviation below the expected normal values (mean below 50), demonstrating reduced physical health compared to the normal population.
Anthropometric data on waist and hip circumferences and WHR and body composition data by sex are shown in Table 3 . The results are broken down by sex, because cut off values for the variables tested are different for men and women. Two patients' bioelectrical impedance data (1 man in the PAD group and one woman with ABI>1.4) could not be acquired because of technical problems at the exact moment of clinical evaluation. Figure 1 illustrates the results for the Spearman coefficients for correlations between ABI and the following variables: age, diabetes duration (time in years since the date of diagnosis, as reported by the patient), SBP and DBP. Correlations between these variables and ABI were significant and the correlation coefficients were negative in all cases. None of the other variables tested exhibited significant correlations (ABI vs. PHS, P=0.30 and ρ=-0.13; ABI vs. MHS, P=0.47, ρ=-0.09; ABI vs. Baecke TS, P=0.72 and ρ=0.04; ABI vs. BMI, P=0.50 and ρ=0.08). Table 4 lists the Spearman coefficients for correlations between ABI and the anthropometric variables and body composition. There was a trend towards lower fat free mass (P=0.05) and skeletal muscle mass (P=0.06) among women with lower ABI results. 
DISCUSSION
Very few studies have assessed the prevalence or impact of PAD in patients with diabetes in the Brazilian population. To our knowledge, this is the first study to assess the prevalence of PAD in T2DM patients with no prior diagnosis of PAD, treated by the public health system in Northeast Brazil. The prevalence of PAD in this population was 13.7%. The ABI results were inversely correlated with age, diabetes duration and arterial blood pressure. The predominant disease classification was mild and, although the DM population had worse scores on the physical health summary of the general health questionnaire, at this degree of severity the presence of PAD had not yet been reflected in significant changes to quality of life, physical activity levels or body composition.
The prevalence of lower-extremity PAD in the general population has been determined in a series of epidemiological investigations that have used intermittent claudication or abnormal ABI as the criterion for diagnosis. 1, 2, 4, 5 Important epidemiological studies such as the Rotterdam study 2 have found PAD prevalence rates of 19.1% in the elderly. The Edinburgh Artery Study 1 described a similar prevalence for the general population above 55 years, but the observed prevalence of intermittent claudication was only 4.5%. The prevalence of PAD in the general Brazilian population 4 was 10.5% in a study of a total of 1159 participants distributed across all five of Brazil's geographical regions. In the Northeast of Brazil, which is the same geographical area in which the present study was conducted, prevalence was 14.9%.
This study found a 13.9% prevalence of PAD among a sample of T2DM patients treated by the public health system at a University Hospital, slightly higher than the prevalence described for the general Brazilian population. 4 It is important to point out that although a validated claudication symptoms questionnaire was not administered, patients were asked specifically about claudication and responded that they did not suffer from claudication. Moreover, the population included in the study comprised a sample of volunteers who were free from complications secondary to DM and had no prior diagnoses of PAD (as defined in the inclusion criteria). The results of this study are consistent with the values reported in the Hoorn study, 5 in which the range of PAD prevalence was approximately 15-20% in patients defined as diabetics according to the criteria adopted for the study. 2 As has been demonstrated in previous studies 2, 4, 25, 26 and confirmed in the present study, advancing age was correlated with increased prevalence of PAD. Significant correlations were observed between ABI and age, ABI and patient-reported diabetes duration, and between ABI and arterial blood pressure, in line with previous findings reported by Yu et al. 27 In the present study, patients with diabetes had lower scores on the physical component summary of the general health questionnaire, when compared to the standardized general population score. Nevertheless, the presence of PAD did not significantly alter the values of either the physical or mental health summaries. Similarly, there was no correlation between ABI and PCS or MCS. A likely explanation is related to the fact that the volunteers in this study had mild PAD (with the majority of abnormal ABI values falling within the range from 0.8 to 0.9) 21,28 and were asymptomatic for intermittent claudication, with the result that at this stage they had no functional limitations resulting from the disease that could directly interfere with quality of life. Long et al. 14 between PCS and ABI (r=0.25) to the figure reported here. These authors concluded that it is the severity of symptoms rather than ABI itself that is determinant of lower scores on the health-related quality of life questionnaire. Physical activity as assessed by the modified Baecke questionnaire was not different between patients with normal ABI and PAD ABI. There was no significant correlation between the ABI values and the Baecke questionnaire total scores. It is possible that changes in physical activity level are not greatly impaired in T2DM patients with mildly reduced ABI. It is also possible that the questionnaire does not offer the necessary specificity to enable detection of changes in the physical activity levels of T2DM patients caused by mild to moderate PAD. However, it should be noted that the T2DM population studied here had mean values for the questionnaire domains that were consistent with low levels of physical activity, according to findings published by Hertogh et al., 29 who compared Baecke questionnaire scores with results for total expended energy, measured using the doubly labeled water method.
Assessment of the body composition of the population enrolled on this study showed that values for FM, PBF and BFMI were all above the normal levels, as predicted for the general population (Caucasians) by Kyle et al., 30 who also used the bioelectrical impedance method. Notwithstanding, in both sexes there was no identifiable impact from PAD on the values of the body composition variables studied, with the exception of BFP in men. It should be borne in mind that the low number of subjects restricts the statistical power available for comparison between groups, especially for men in the PAD ABI group. This study limitation is the result of employing a convenience sample and the fact that patients were not selected based on diagnosis of PAD, but were randomly identified in a population of T2DM patients.
Overall, the majority of women in the present study had PBF results above the cut-off values. For example, 95.8% of women in the age group ranging from 40 to 59 years old were above predicted normal values. 30 The same is true for men in that age group (77.8% are above cut-off values). Moreover, there was a predominance of central fat (indicated by WHR and segmental impedance) in this population, especially among the women, which increases their cardiovascular risk. 18 There was a strong trend towards correlations between fat-free mass (P=0.05) and skeletal muscle mass (P=0.06) and ABI values in women, but a more comprehensive study of T2DM patients with lower ABI levels, or perhaps with symptomatic PAD, will be needed to clarify whether PAD could have a negative impact on body composition variables.
The present study suffers from a limitation in terms of sample size, making it difficult to extrapolate the prevalence found in this T2DM sample to a larger population, such as the national Brazilian population, but it nevertheless provides new and important data for raising awareness of PAD in DM. The ABI method is widely accepted and recommended for PAD diagnosis, 3, 21, 22 especially in epidemiological studies, but it must be acknowledged that there is a possibility that it may be insufficient to enable full diagnosis in DM patients, in view of the high frequency of abnormal ABI values found, as the present study has shown.
In summary, this study demonstrated that PAD newly identified in T2DM patients, which was predominantly of mild severity and asymptomatic, was not associated with reduced physical function or impaired quality of life, as assessed by validated questionnaires. This implies that T2DM patients who do not perceive physical limitations may not have their PAD identified, thereby missing the chance to prevent major complications, unless clinical assessment of ABI is performed as recommended. 3, 22 Therefore, this study underscores the importance of routine screening of patients with diabetes for PAD, using ABI, because the absence of symptoms or of functional limitations perceived by the patient may hinder clinical diagnosis.
CONCLUSIONS
This study found a 13.7% prevalence of PAD, diagnosed with the ankle-brachial index, in a sample of Brazilian T2DM patients with no prior diagnosis of PAD, treated by the public health system. Among these patients, who predominantly had asymptomatic mild PAD, the condition was not yet associated with further impairment of quality of life, physical activity levels or body composition.
